Evonik is one of the world’s leading specialty chemicals companies. The central elements of our strategy for sustained value creation are profitable growth, efficiency and values. Around 80 percent of sales come from market-leading positions, which we are systematically
expanding. We concentrate on high-growth megatrends, especially health, nutrition, resource efficiency and globalization.
In 2014 Evonik’s roughly 33,000 employees generated sales of €12.91) billion and an operating result (adjusted EBITDA) of €1.9 billion. Around 78 percent of sales are generated outside Germany, providing convincing evidence that our business is global.